Elevation Oncology Announces Pricing of Initial Public Offering ...Middle East

PR Newswire - News
Elevation Oncology Announces Pricing of Initial Public Offering
NEW YORK, June 24, 2021 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, today announced the pricing of its initial public offering of...

Hence then, the article about elevation oncology announces pricing of initial public offering was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Elevation Oncology Announces Pricing of Initial Public Offering )

Apple Storegoogle play

Last updated :

Also on site :



Latest News